Earnings Per Share (EPS) of $1.20, surpassing the estimated $1.17, reflecting the company’s ability to exceed market expectations. Revenue reached approximately $34.1 billion, exceeding forecasts and ...

Q4 2024. Management View. CEO Tracy Robinson acknowledged challenges faced during 2024, including labor disrup ...

Tesla, IBM and Meta Platforms helped lead most U.S. stocks higher after a rush of profit reports from some of the country’s ...

Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...

Roche projects mid-single digit group sales growth in 2025, with core EPS growth in the high-single digit range. The company expects a CHF1.2 billion impact from the loss of exclusivity but aims to ...

Teva Pharmaceutical Industries TEVA reported fourth-quarter 2024 adjusted earnings of 71 cents per share, which beat the ...

While Roche saw a 1 percent decline in full-year 2024 diagnostics sales year over year, the base business within the division rose 8 percent. Overall, Roche reported ...

Regular MarketWatch readers might already be aware that U.S. stocks are historically expensive right now, based on several popular metrics. Some have argued that this could signal that the market has ...